🟢 MEDPAL AI is trading 5% up today; catalyst unclear

MEDPAL AI is trading 5.26% up at £4.00, based on the supplied August 18, 2026 price context; the catalyst remains unclear.

• No new company-specific announcement was identified on August 18; the latest listed RNS was the August 11 update on UK authorisation of Eli Lilly’s oral GLP-1 pill.
• Broader markets were weaker, with Nasdaq futures down more than 1% amid higher oil prices, geopolitical tensions and elevated bond yields; these factors do not directly explain MEDPAL AI’s gain.